Also trades as: CMRAW (NASDAQ) · $vol 0M
CMRA OTC
Comera Life Sciences Holdings, Inc.
1W: -0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
InsiderStreet Scorecard
Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.
★
★
★
★
★
32
Grade D
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores.
CMRA scores highest in Growth (88/100) and lowest in Balance Sheet (0/100).
A grade of D flags significant fundamental concerns across multiple dimensions.
Risk & Quality Signals
Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.
Altman Z-Score
-27.55
Distress Zone
Piotroski F-Score
4/9
✗
✗
✓
✓
✓
✗
✗
✗
✓
Beneish M-Score
-6.80
Unlikely Manipulator
Ohlson O-Score
14.17
Bankruptcy prob: 100.0%
High Risk
Credit Rating
CCC
Score: 17.8/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.74x
Accruals: -58.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor.
CMRA scores -27.55, placing it in the Distress Zone (safe > 2.99, distress < 1.81).
Historically, companies in this range face elevated bankruptcy risk.
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point.
CMRA scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others.
The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators.
CMRA's score of -6.80 falls below this threshold, suggesting earnings are unlikely to be manipulated.
The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation.
CMRA's implied 100.0% bankruptcy probability signals significant financial distress.
Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation.
CMRA receives an estimated rating of CCC (score: 17.8/100), with a deteriorating trend.
Valuation
Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.
P/E
-0.00x
PEG
-0.00x
P/S
0.00x
P/B
-0.00x
P/FCF
-0.19x
P/OCF
—
EV/EBITDA
-0.58x
EV/Revenue
5.14x
EV/EBIT
-0.57x
EV/FCF
-0.15x
Earnings Yield
-133.72%
FCF Yield
-524.48%
Shareholder Yield
6.73%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay.
CMRA currently has negative earnings — the P/E ratio is not meaningful.
DuPont Decomposition (5-Factor)
The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.
Tax Burden
1.000
NI / EBT
Interest Burden
1.003
EBT / EBIT
EBIT Margin
-8.980
EBIT / Rev
Asset Turnover
0.250
Rev / Assets
Equity Multiplier
-1.047
Assets / Equity
ROE
235.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability.
CMRA's ROE of 235.6% is driven by
Asset Turnover (0.250), indicating efficient use of assets to generate revenue.
A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.
Graham-Dodd Adjusted Valuation
Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.
Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.
Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—
Profitability Trends
Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.
Leverage & Solvency Trends
Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.
Efficiency & Working Capital Trends
Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.
Growth Trends (YoY %)
Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.
Earnings Stability
R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1447 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
786.6%
25th–75th percentile
5th–95th percentile
Median path
Historical
Executive Compensation
C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.
C-Suite Compensation
| Executive | Salary | Stock | Total |
|---|---|---|---|
Michael G. Campbell, Chief Financial Officer |
$201,882 | $— | $1,156,782 |
Jeffrey S. Hackman, Chief Executive Officer |
$400,000 | $— | $935,200 |
Neal Muni, MD, Chief Operating Officer |
$350,000 | $— | $439,200 |
CEO Pay Ratio
1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $935,200
Avg Employee Cost (SGA/emp): $887,741
Employees: 12
C-Suite Pay Equality (Gini)
CEO Compensation Mix
Workforce & Productivity
Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.
Employees
12
Revenue / Employee
$52,759
Rev: $633,102
Profit / Employee
$-1,500,342
NI: $-18,004,098
SGA / Employee
$887,741
Avg labor cost proxy
R&D / Employee
$144,986
Innovation spend
Scaling Efficiency
All Ratios & Metrics
Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.
Profitability
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -3.5% | -16.5% | -3.5% | -88.3% | 92.1% | 18.2% | -35.9% | 474.5% | 1.6% | 2.4% | 2.4% | 2.36% | |
| ROA | -97.7% | -4.6% | -3.2% | -73.5% | -2.8% | -4.5% | -30.3% | -3.2% | -4.4% | -2.3% | -2.2% | -2.25% | |
| ROIC | -3.5% | -13.1% | -2.8% | 275.4% | 27.9% | 1.2% | 1.8% | 1.6% | 1.5% | 1.2% | 1.2% | 1.24% | |
| ROCE | 13.6% | 7.3% | 1.3% | -11.8% | -2.0% | -4.2% | -11.4% | 13.5% | 49.4% | 6.1% | -64.4% | -64.39% | |
| Gross Margin | 81.6% | 18.8% | 44.9% | 46.9% | 53.3% | 62.8% | 74.0% | 67.7% | 70.3% | 82.2% | 69.2% | 69.22% | |
| Operating Margin | -7.9% | -26.8% | -10.4% | -27.6% | -25.7% | -27.1% | -10.8% | -19.3% | -6.4% | -4.7% | -15.8% | -15.82% | |
| Net Margin | -6.1% | -27.9% | -10.4% | -27.6% | -30.2% | -61.9% | -13.1% | -19.0% | -6.3% | -4.5% | -15.8% | -15.80% | |
| EBITDA Margin | 48.6% | -27.6% | -10.2% | -28.4% | -29.9% | -61.8% | -12.9% | -18.8% | -6.2% | -4.4% | -15.6% | -15.59% | |
| FCF Margin | -5.6% | -7.7% | -8.8% | -12.2% | -19.2% | -20.4% | -17.6% | -60.6% | -40.3% | -32.6% | -35.3% | -35.32% | |
| OCF Margin | -5.6% | -7.7% | -8.7% | -11.7% | -18.7% | -20.0% | -17.3% | -15.4% | -9.5% | -6.5% | -6.7% | -6.66% | |
| ROA 3Y Avg | snapshot only | -2.14% | |||||||||||
| ROIC Economic | snapshot only | 1.78% | |||||||||||
| Cash ROA | snapshot only | -2.17% | |||||||||||
| NOPAT Margin | snapshot only | -7.22% | |||||||||||
| Pretax Margin | snapshot only | -9.01% | |||||||||||
| R&D / Revenue | snapshot only | 1.43% | |||||||||||
| SGA / Revenue | snapshot only | 8.44% | |||||||||||
| SBC / Revenue | snapshot only | 99.57% | |||||||||||
Valuation
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -247.26 | -76.23 | -56.02 | -35.47 | -24.97 | -1.44 | -1.51 | -1.14 | -0.97 | -0.94 | -0.75 | -0.000 | |
| P/S Ratio | 1501.93 | 1207.30 | 778.98 | 604.55 | 594.74 | 53.32 | 46.88 | 32.42 | 18.39 | 8.49 | 6.73 | 0.005 | |
| P/B Ratio | 868.19 | 1261.46 | 1.95 | 31.33 | -11.39 | -11.99 | -7.53 | -3.29 | -3.25 | -1.47 | -1.60 | -0.000 | |
| P/FCF | -268.74 | -156.99 | -88.66 | -49.58 | -31.01 | -2.62 | -2.66 | -0.53 | -0.46 | -0.26 | -0.19 | -0.191 | |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV/EBITDA | 30.89 | 82.97 | 135.36 | -279.98 | -24.52 | -1.14 | -1.43 | -1.17 | -0.91 | -0.99 | -0.58 | -0.579 | |
| EV/Revenue | 1501.99 | 1207.33 | 777.15 | 585.20 | 583.84 | 42.09 | 44.35 | 32.94 | 17.02 | 8.79 | 5.14 | 5.139 | |
| EV/EBIT | 31.05 | 84.53 | 141.55 | -248.02 | -24.25 | -1.13 | -1.42 | -1.16 | -0.90 | -0.98 | -0.57 | -0.572 | |
| EV/FCF | -268.75 | -156.99 | -88.45 | -47.99 | -30.44 | -2.07 | -2.52 | -0.54 | -0.42 | -0.27 | -0.15 | -0.145 | |
| Earnings Yield | -0.4% | -1.3% | -1.8% | -2.8% | -4.0% | -69.3% | -66.1% | -87.7% | -1.0% | -1.1% | -1.3% | -1.34% | |
| FCF Yield | -0.4% | -0.6% | -1.1% | -2.0% | -3.2% | -38.2% | -37.5% | -1.9% | -2.2% | -3.8% | -5.2% | -5.24% | |
| EV/Gross Profit | snapshot only | 6.990 | |||||||||||
| Shareholder Yield | snapshot only | 6.73% | |||||||||||
Leverage & Solvency
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.33 | 1.33 | 402.07 | 6.49 | 4.26 | 2.14 | 1.25 | 0.61 | 0.72 | 0.46 | 0.90 | 0.897 | |
| Quick Ratio | 1.24 | 1.24 | 402.07 | 6.49 | 3.91 | 2.03 | 0.88 | 0.61 | 0.56 | 0.46 | 0.90 | 0.897 | |
| Debt/Equity | 1.06 | 1.06 | 0.00 | 0.05 | -0.02 | -0.23 | -0.37 | -0.12 | -0.05 | -0.13 | -0.04 | -0.041 | |
| Net Debt/Equity | 0.03 | 0.03 | -0.00 | -1.00 | — | — | — | — | — | — | — | — | |
| Debt/Assets | 0.29 | 0.29 | 0.00 | 0.04 | 0.06 | 0.07 | 0.26 | 0.21 | 0.09 | 0.34 | 0.06 | 0.056 | |
| Debt/EBITDA | 0.04 | 0.07 | 0.00 | -0.48 | -0.04 | -0.03 | -0.07 | -0.04 | -0.02 | -0.08 | -0.02 | -0.019 | |
| Net Debt/EBITDA | 0.00 | 0.00 | -0.32 | 9.26 | 0.46 | 0.30 | 0.08 | -0.02 | 0.07 | -0.03 | 0.18 | 0.180 | |
| Interest Coverage | — | — | — | — | -102357.68 | -194626.48 | -1341.63 | -881.94 | -629.32 | -310.27 | -356.82 | -356.822 | |
| Equity Multiplier | 3.59 | 3.59 | 1.09 | 1.20 | -0.29 | -3.42 | -1.44 | -0.60 | -0.57 | -0.37 | -0.73 | -0.728 | |
| Cash Ratio | snapshot only | 0.603 | |||||||||||
| Debt Service Coverage | snapshot only | -352.856 | |||||||||||
| Cash to Debt | snapshot only | 10.303 | |||||||||||
| FCF to Debt | snapshot only | -205.931 | |||||||||||
| Defensive Interval | snapshot only | 69.0 days | |||||||||||
Efficiency & Turnover
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.16 | 0.29 | 0.00 | 0.04 | 0.12 | 0.12 | 0.01 | 0.11 | 0.23 | 0.26 | 0.25 | 0.250 | |
| Inventory Turnover | 0.74 | 3.36 | — | 80.50 | 0.99 | 1.19 | 0.31 | 210.39 | 0.63 | 1.95 | 0.42 | 0.416 | |
| Receivables Turnover | 0.80 | 1.44 | — | 3.76 | 2.54 | 3.84 | 3.75 | 10.61 | 4.69 | 6.28 | 5.08 | 5.080 | |
| Payables Turnover | 0.17 | 0.76 | — | 0.39 | 0.52 | 0.24 | 0.28 | 0.22 | 0.23 | 0.16 | 0.21 | 0.205 | |
| DSO | 457 | 253 | 0 | 97 | 144 | 95 | 97 | 34 | 78 | 58 | 72 | 71.8 days | |
| DIO | 496 | 109 | 0 | 5 | 368 | 307 | 1169 | 2 | 579 | 188 | 878 | 878.0 days | |
| DPO | 2207 | 483 | 0 | 945 | 703 | 1492 | 1318 | 1627 | 1553 | 2299 | 1779 | 1778.6 days | |
| Cash Conversion Cycle | -1255 | -122 | 0 | -844 | -190 | -1090 | -52 | -1590 | -897 | -2054 | -829 | -828.8 days | |
| Fixed Asset Turnover | snapshot only | 2.873 | |||||||||||
| Operating Cycle | snapshot only | 949.8 days | |||||||||||
| Cash Velocity | snapshot only | 0.566 | |||||||||||
| Capital Intensity | snapshot only | 3.071 | |||||||||||
Growth (YoY)
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | 2.7% | 1.5% | 1.2% | 97.9% | 1.8% | 1.7% | 81.8% | 81.79% | |
| Net Income | — | — | — | — | -13.6% | -4.9% | -4.0% | -2.3% | -1.3% | 33.4% | 47.2% | 47.21% | |
| EPS | — | — | — | — | -9.1% | -12.9% | -4.9% | -2.8% | -1.3% | 71.7% | 63.4% | 63.40% | |
| FCF | — | — | — | — | -11.8% | -5.7% | -3.5% | -8.8% | -5.0% | -3.4% | -2.6% | -2.65% | |
| EBITDA | — | — | — | — | -2.8% | -7.4% | -13.0% | -25.8% | -1.2% | 34.2% | 47.9% | 47.87% | |
| Op. Income | — | — | — | — | -9.5% | -2.6% | -2.1% | -1.2% | -64.8% | -1.7% | 16.7% | 16.73% | |
| OCF Growth | snapshot only | 30.09% | |||||||||||
| Asset Growth | snapshot only | -37.78% | |||||||||||
| Debt Growth | snapshot only | -86.57% | |||||||||||
| Shares Change | snapshot only | 44.24% | |||||||||||
Growth Quality
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue Stability | — | — | — | — | — | — | — | — | 0.94 | 0.93 | 0.99 | 0.988 | |
| Earnings Stability | — | — | — | — | — | — | — | — | 0.99 | 0.35 | 0.17 | 0.166 | |
| Margin Stability | — | — | — | — | — | — | — | — | 0.69 | 0.80 | 0.82 | 0.815 | |
| Rev. Growth Consistency | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | 0.50 | 0.50 | 0.50 | 1.00 | 1.00 | 1.00 | 1.000 | |
| Earn. Growth Consistency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | 0.50 | 0.500 | |
| FCF Positive Streak | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Earnings Persistence | — | — | — | — | — | — | — | — | 0.50 | 0.87 | 0.81 | 0.811 | |
| Earnings Smoothness | — | — | — | — | — | — | — | — | — | — | — | — | |
| ROE Trend | — | — | — | — | — | — | — | — | — | — | — | — | |
| Gross Margin Trend | — | — | — | — | — | — | — | — | 0.08 | 0.21 | 0.16 | 0.164 | |
| FCF Margin Trend | — | — | — | — | — | — | — | — | -27.92 | -18.57 | -22.13 | -22.128 | |
| Sustainable Growth Rate | — | — | — | — | — | — | — | — | — | — | — | — | |
| Internal Growth Rate | — | — | — | — | — | — | — | — | — | — | — | — |
Cash Flow Quality
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OCF/Net Income | 0.92 | 0.49 | 0.63 | 0.69 | 0.79 | 0.54 | 0.56 | 0.54 | 0.50 | 0.72 | 0.74 | 0.739 | |
| FCF/OCF | 1.00 | 1.00 | 1.01 | 1.04 | 1.02 | 1.02 | 1.02 | 3.93 | 4.26 | 5.02 | 5.30 | 5.305 | |
| FCF/Net Income | snapshot only | 3.922 | |||||||||||
| CapEx/Revenue | 0.0% | 0.0% | 4.7% | 44.4% | 43.4% | 36.1% | 28.9% | 45.2% | 30.8% | 26.1% | 28.7% | 28.66% | |
| CapEx/Depreciation | snapshot only | 287.158 | |||||||||||
| Accruals Ratio | -0.08 | -2.37 | -0.01 | -0.23 | -0.60 | -2.05 | -0.13 | -1.48 | -2.21 | -0.66 | -0.59 | -0.586 | |
| Sloan Accruals | snapshot only | -0.315 | |||||||||||
| Cash Flow Adequacy | snapshot only | -0.232 | |||||||||||
Dividends & Buybacks
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.00% | |
| Dividend/Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — | — | |
| FCF Payout Ratio | — | — | — | — | — | — | — | — | — | — | — | — | |
| Total Payout Ratio | — | — | — | — | — | — | — | — | — | — | — | — | |
| Div. Increase Streak | — | — | — | — | — | — | — | — | — | — | — | — | |
| Chowder Number | — | — | — | — | — | — | — | — | — | — | — | — | |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 6.7% | 6.73% | |
| Net Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -18.5% | -18.3% | -23.4% | -28.3% | -9.4% | -52.4% | -52.39% | |
| Total Shareholder Return | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -18.5% | -18.3% | -23.4% | -28.3% | -9.4% | -52.4% | -52.39% |
DuPont Factors
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax Burden (NI/EBT) | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.000 | |
| Interest Burden (EBT/EBIT) | -0.13 | -1.11 | -2.53 | 7.22 | 0.99 | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.003 | |
| EBIT Margin | 48.37 | 14.28 | 5.49 | -2.36 | -24.08 | -37.17 | -31.14 | -28.41 | -18.89 | -9.01 | -8.98 | -8.980 | |
| Asset Turnover | 0.16 | 0.29 | 0.00 | 0.04 | 0.12 | 0.12 | 0.01 | 0.11 | 0.23 | 0.26 | 0.25 | 0.250 | |
| Equity Multiplier | 3.59 | 3.59 | 1.09 | 1.20 | -0.33 | -4.07 | 1.19 | -146.87 | -0.36 | -1.04 | -1.05 | -1.047 |
Per Share
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (Diluted TTM) | $-0.04 | $-0.13 | $-0.18 | $-0.29 | $-0.41 | $-1.83 | $-1.07 | $-1.08 | $-0.93 | $-0.52 | $-0.39 | $-0.39 | |
| Book Value/Share | $0.01 | $0.01 | $5.15 | $0.32 | $-0.90 | $-0.22 | $-0.21 | $-0.37 | $-0.28 | $-0.33 | $-0.18 | $-0.60 | |
| Tangible Book/Share | $0.01 | $0.01 | $5.15 | $0.32 | $-0.90 | $-0.22 | $-0.21 | $-0.37 | $-0.28 | $-0.33 | $-0.18 | $-0.18 | |
| Revenue/Share | $0.01 | $0.01 | $0.01 | $0.02 | $0.02 | $0.05 | $0.03 | $0.04 | $0.05 | $0.06 | $0.04 | $0.06 | |
| FCF/Share | $-0.04 | $-0.06 | $-0.11 | $-0.20 | $-0.33 | $-1.01 | $-0.60 | $-2.30 | $-1.97 | $-1.87 | $-1.53 | $-0.94 | |
| OCF/Share | $-0.04 | $-0.06 | $-0.11 | $-0.20 | $-0.32 | $-0.99 | $-0.59 | $-0.59 | $-0.46 | $-0.37 | $-0.29 | $-0.93 | |
| Cash/Share | $0.01 | $0.01 | $0.02 | $0.34 | $0.20 | $0.61 | $0.17 | $0.03 | $0.08 | $0.02 | $0.08 | $0.04 | |
| EBITDA/Share | $0.32 | $0.12 | $0.07 | $-0.04 | $-0.41 | $-1.83 | $-1.06 | $-1.07 | $-0.92 | $-0.51 | $-0.38 | $-0.38 | |
| Debt/Share | $0.01 | $0.01 | $0.00 | $0.02 | $0.02 | $0.05 | $0.08 | $0.05 | $0.01 | $0.04 | $0.01 | $0.01 | |
| Net Debt/Share | $0.00 | $0.00 | $-0.02 | $-0.32 | $-0.19 | $-0.56 | $-0.09 | $0.02 | $-0.07 | $0.02 | $-0.07 | $-0.07 |
Academic Models
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Altman Z-Score | — | — | — | — | — | — | — | — | — | — | — | -27.552 | |
| Altman Z-Prime | snapshot only | -62.785 | |||||||||||
| Piotroski F-Score | 2 | 2 | 2 | 2 | 3 | 6 | 4 | 4 | 4 | 4 | 4 | 4 | |
| Beneish M-Score | — | — | — | — | -4.06 | -7.55 | -15.58 | -12.60 | -13.83 | -7.11 | -6.80 | -6.797 | |
| Ohlson O-Score | snapshot only | 14.166 | |||||||||||
| Net-Net WC | snapshot only | $-0.20 | |||||||||||
Credit
| Metric | Trend | Q1'21 | Q2'21 | Q3'21 | Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Credit Rating | snapshot only | CCC | |||||||||||
| Credit Score | 64.09 | 64.03 | 89.00 | 60.52 | 20.00 | 20.00 | 19.70 | 14.95 | 15.26 | 12.75 | 17.79 | 17.789 | |
| Credit Grade | snapshot only | 17 | |||||||||||
| Credit Trend | snapshot only | -1.908 | |||||||||||
| Implied Spread (bps) | snapshot only | 1200.000 | |||||||||||
| Industry Credit Rank | snapshot only | 8 | |||||||||||
| Sector Credit Rank | snapshot only | 9 | |||||||||||